Method: IHC
Measures the level of PDL1 protein in tumour tissue. PDL1 is a protein that some cancers use to hide from the immune system. High PDL1 levels predict whether immunotherapy drugs (checkpoint inhibitors) are likely to work.
Immunotherapy has transformed cancer treatment, but it works best in tumours with high PDL1 expression. This test tells your oncologist whether immunotherapy is the right choice for your cancer.
No preparation needed — the test is performed on tumour tissue already collected during a biopsy or surgery.
Price (MRP)
NPR 14,000
Order as a gift© 2026 Aashirbad Care. All rights reserved.